TABLE 2.

Scenario Analysis, Cost Difference per Treated Patient

Scenario	Cost difference per patient, $
Baselinea	64,770.25
No wastage	1,591.19
Medicare	67,426.84
Medicaid	42,680.68
No difference in administration costs	59,393.09
No difference in monitoring costs	65,475.63
Use WAC pricing for both (commercial)	74,828.63
Romiplostim 125 μg vial	18,961.77

^aBase-case values reflect the following inputs: commercial plan, including wastage costs, ASP pricing for romiplostim, default values for pricing and dosage. Base case under these inputs is $64,770.

ASP = average sales price; WAC = wholesale acquisition cost.